Concourse Financial Group Securities, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 55 shares of REGN stock, worth $45,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55
Previous 46
19.57%
Holding current value
$45,346
Previous $48,000
18.75%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.42 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.96 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$6.82 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$3.99 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.82 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $88.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...